Glycosaminoglycans in infectious disease

Biol Rev Camb Philos Soc. 2013 Nov;88(4):928-43. doi: 10.1111/brv.12034. Epub 2013 Mar 29.

Abstract

Glycosaminoglycans (GAGs) are complex carbohydrates that are ubiquitously present on the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens represent the first line of contact between pathogen and host cell and are crucial to a pathogen's invasive potential. Their complexity and structural diversity allow GAGs to control a wide array of biological interactions influencing many physiological and pathological processes, including adhesion, cell-to-cell communication, biochemical cascades, and the immune response. In recent years, increasing evidence indicates an extraordinary role for GAGs in the pathogenesis of viruses, bacteria and parasites. Herein, we examine the interface between GAGs and different pathogens, and address the divergent biological functions of GAGs in infectious disease. We consider approaches to use this understanding to design novel therapeutic strategies addressing new challenges in the treatment of infectious diseases.

Keywords: bacteria; glycosamimoglycans; infectious disease; parasites; protein-carbohydrate interactions; virus.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Communication
  • Communicable Diseases / immunology
  • Communicable Diseases / metabolism*
  • Gene Expression Regulation
  • Glycosaminoglycans / genetics
  • Glycosaminoglycans / metabolism*
  • Host-Pathogen Interactions

Substances

  • Glycosaminoglycans